UY26036A1 - Procedimiento para preparar ciertas caprolactamas sustituidas - Google Patents

Procedimiento para preparar ciertas caprolactamas sustituidas

Info

Publication number
UY26036A1
UY26036A1 UY26036A UY26036A UY26036A1 UY 26036 A1 UY26036 A1 UY 26036A1 UY 26036 A UY26036 A UY 26036A UY 26036 A UY26036 A UY 26036A UY 26036 A1 UY26036 A1 UY 26036A1
Authority
UY
Uruguay
Prior art keywords
compound
formula
cycloalkyl
procedure
alkyl
Prior art date
Application number
UY26036A
Other languages
English (en)
Inventor
Frederick Ray Kinder
Kenneth Walther Bair
Christopher Jagoe
Richard William Versace
Sompong Wattanasin
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of UY26036A1 publication Critical patent/UY26036A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D223/00Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08Oxygen atoms
    • C07D223/10Oxygen atoms attached in position 2
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Proceso para la preparación de un compuesto de caprolactama, de fórmula (I), sustituida, en donde: R1 es alquilo o cicloaqluilo; R2 es hidrógeno o alquilo; X es alquileno, alquenileno o alquinileno; m es 0 o 1; y R3 es cicloalquilo, o un sistema de anillos aromáticos seleccionado a partir de II, III. IV y V (ver figuras), o una sal de adición de ácido farmacéuticamente aceptable del mismo, cuando sea posible, cuyo proceso comprende, en un primer paso, acilar un compuesto de aminocaprolactama de la fórmula VI, o con un compuesto de lactona de fórmula VII, en presencia de un solvente orgánico polar, para obtener un compuesto de diamida de la de la fórmula VIII, en donde cada uno de R1, R2, X, m y R3 es como se define anteriormente, y en un segundo paso, hidrolizar el compuesto de diamida obtenido en el primer paso, mediante su disolución en una mezcla de solventes, para obtener el compuesto de caprolactama deseado de la fórmula (I). Por ejemplo: (2R,3R,4S,5R,6E)-3,4,5-trihidroxi-2-metoxi-8,8-dimetil-N-((3S,6R)-hexahidro-2-oxo-6-(cicloheptilcarbonil)oxi-2H-azepin-3-il)non-6-enamida. Estos compuestos son útiles para el tratamiento de tumores.
UY26036A 1998-11-17 2000-02-25 Procedimiento para preparar ciertas caprolactamas sustituidas UY26036A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US19335498A 1998-11-17 1998-11-17

Publications (1)

Publication Number Publication Date
UY26036A1 true UY26036A1 (es) 2001-06-29

Family

ID=22713307

Family Applications (2)

Application Number Title Priority Date Filing Date
UY25807A UY25807A1 (es) 1998-11-17 1999-11-17 Caprolactamas sustituidas, composiciones farmacéuticas que las contienen, y su uso en el tratamiento de tumores.
UY26036A UY26036A1 (es) 1998-11-17 2000-02-25 Procedimiento para preparar ciertas caprolactamas sustituidas

Family Applications Before (1)

Application Number Title Priority Date Filing Date
UY25807A UY25807A1 (es) 1998-11-17 1999-11-17 Caprolactamas sustituidas, composiciones farmacéuticas que las contienen, y su uso en el tratamiento de tumores.

Country Status (25)

Country Link
EP (1) EP1131297B1 (es)
JP (1) JP3550545B2 (es)
KR (1) KR20010080461A (es)
CN (1) CN1187333C (es)
AR (1) AR023914A1 (es)
AT (1) ATE264309T1 (es)
AU (1) AU748016B2 (es)
BR (1) BR9915436A (es)
CA (1) CA2347773C (es)
CO (1) CO5140099A1 (es)
CZ (1) CZ20011707A3 (es)
DE (1) DE69916488T2 (es)
ES (1) ES2221463T3 (es)
HU (1) HUP0104224A3 (es)
ID (1) ID28343A (es)
IL (1) IL142701A0 (es)
NO (1) NO20012428L (es)
PE (1) PE20001241A1 (es)
PL (1) PL347633A1 (es)
PT (1) PT1131297E (es)
SK (1) SK6692001A3 (es)
TR (1) TR200101366T2 (es)
UY (2) UY25807A1 (es)
WO (1) WO2000029382A1 (es)
ZA (1) ZA200103419B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003532711A (ja) * 2000-05-11 2003-11-05 ノバルティス アクチエンゲゼルシャフト 置換カプロラクタム炭酸エステルおよびカプロラクタムエーテル、およびそれらの抗腫瘍薬としての使用
WO2002072555A1 (en) * 2001-03-12 2002-09-19 Novartis Ag Process for preparing certain substituted caprolactams
CN1856486A (zh) * 2003-07-25 2006-11-01 诺瓦提斯公司 取代的内酰胺和它们作为抗癌剂的用途
DE10349669B3 (de) * 2003-10-24 2005-05-25 Aventis Pharma Deutschland Gmbh Bengamide-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung
US7153846B2 (en) 2003-10-24 2006-12-26 Sanofi-Aventis Deutschland Gmbh Bengamide derivatives, process for preparing them, and their use
FR2878525B1 (fr) 2004-11-29 2007-02-23 Aventis Pharma Sa Bengamides possedant un cycle caprolactame substitue, procede de preparation, compositions les contenant et utilisation
FR2878528B1 (fr) 2004-11-29 2008-05-16 Aventis Pharma Sa 2-alcoxy-3,4,5-trihydroxy-alkylamides, leur preparation, compositions les contenant et utilisation
FR2901555A1 (fr) 2006-05-24 2007-11-30 Sanofi Aventis Sa 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzothiazepine, leur preparation, compositions les contenant et utilisation
FR2901556A1 (fr) * 2006-05-24 2007-11-30 Sanofi Aventis Sa Derives de 2-alcoxy-3,4,5-trihydroxy-alkylamide, leur preparation, compositions les contenant et utilisation
FR2901554B1 (fr) 2006-05-24 2011-04-01 Sanofi Aventis 2-alcoxy-3,4,5-trihydroxy-alkylamide-benzazepine, leur preparation, compositions les contenant et utilisation
EP2582680A1 (en) 2010-06-17 2013-04-24 Novartis AG Biphenyl substituted 1,3-dihydro-benzoimidazol-2-ylideneamine derivatives
JP2013532149A (ja) 2010-06-17 2013-08-15 ノバルティス アーゲー ピペリジニル置換1,3−ジヒドロ−ベンゾイミダゾール−2−イリデンアミン誘導体

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9411841D0 (en) * 1994-06-14 1994-08-03 Pharma Mar Sa New antitumoral compounds from jaspis sponge

Also Published As

Publication number Publication date
PT1131297E (pt) 2004-08-31
BR9915436A (pt) 2001-08-07
CA2347773A1 (en) 2000-05-25
PL347633A1 (en) 2002-04-22
NO20012428L (no) 2001-07-17
CO5140099A1 (es) 2002-03-22
EP1131297B1 (en) 2004-04-14
DE69916488D1 (de) 2004-05-19
CZ20011707A3 (cs) 2001-08-15
PE20001241A1 (es) 2000-11-24
AU1506000A (en) 2000-06-05
CN1187333C (zh) 2005-02-02
AR023914A1 (es) 2002-09-04
NO20012428D0 (no) 2001-05-16
UY25807A1 (es) 2001-08-27
SK6692001A3 (en) 2001-10-08
JP2002529536A (ja) 2002-09-10
ES2221463T3 (es) 2004-12-16
JP3550545B2 (ja) 2004-08-04
WO2000029382A1 (en) 2000-05-25
KR20010080461A (ko) 2001-08-22
TR200101366T2 (tr) 2001-10-22
ATE264309T1 (de) 2004-04-15
ZA200103419B (en) 2002-06-26
ID28343A (id) 2001-05-17
DE69916488T2 (de) 2005-03-24
AU748016B2 (en) 2002-05-30
CN1326445A (zh) 2001-12-12
EP1131297A1 (en) 2001-09-12
IL142701A0 (en) 2002-03-10
HUP0104224A3 (en) 2002-04-29
CA2347773C (en) 2009-03-10
HUP0104224A2 (hu) 2002-03-28

Similar Documents

Publication Publication Date Title
UY26036A1 (es) Procedimiento para preparar ciertas caprolactamas sustituidas
LTC2371361I2 (lt) Pirmtakų/kamieninių ląstelių suaktyvinimo būdai
CN1131215C (zh) 环和杂环N-取代的α-亚氨基异羟肟酸和羧酸
BR0112068A (pt) Compostos orgânicos
KR960034204A (ko) 항-천식 작용을 지닌 피리도[3,2-e]피라지논 및 이의 제조방법
RU2002111333A (ru) Способ получения производных 4''-замещенных 9-деоксо-9а-аза-9а-гомоэритромицина а
KR960705776A (ko) 카프로락탐의 제조 방법(process for manufacturing caprolactam)
AR003962A1 (es) Dihidrodibenzo/b,f/azepinas útiles en el tratamiento de algunos desórdenes del sistema nervioso central y períferico, método para preparar dichos compuestos y sus composiciones farmacéuticas,y, sus usos
EA199800522A1 (ru) Способ получения ловастатина
Benedek et al. Efficient Synthesis of Hydroxy‐Substituted Cispentacin Derivatives
Miyata et al. A convenient route to the furopyran core of dysiherbaine
AR027022A1 (es) Un sistema catalizador de blanqueo, una composicion blanqueadora, y un proceso de limpieza.
US6545148B2 (en) Process for preparing certain substituted caprolactams
Liu et al. Alkylation of Sulfur Ligand in Cysteinate‐Iron Chelates by a 1, 2, 4, 5‐Tetraoxane
CN113636980B (zh) 一种右丙亚胺的制备方法
KR910004632A (ko) 신규한 1-옥사-2-옥소-8-아자스피로[4,5]데칸 유도체와 그들을 포함하는 약제학적 조성물 및 그 제조방법
AR007291A1 (es) Nuevos derivados de 10,11-dihidro-10-oxo-5h-dibenz/b, f/azepina-5-carboxamida, metodo de preparacion y su uso en la preparacion de una composicion farmaceutica
CN1041627C (zh) (s)-2,2,2-三氯-n-(2-氯环己-2-烯基)-乙酰胺和(s)-2-氯环己-2-烯胺
RU2003132440A (ru) Способ получения 7-хинолинил-3,5-дигидроксигепт-6-еноата
KR890006643A (ko) β-락탐 항생물질의 모노하이드레이트 및 용매화합물
CN1330651A (zh) 稳定吡唑并吖啶酮衍生物水溶液的方法
PL1654209T3 (pl) Sposób wytwarzania składnika kosmetycznie aktywnego
Dobler et al. Microbial hydroxylation of some synthetic Aristotelia alkaloids
Chung et al. Synthesis of 4-(2-Methoxyethyl)-2-azetidinone
Adinolfi β-Fragmentation of Anomeric Alkoxy Radicals from 1, 3, 4, 5-Tetra-O-benzyl-hex-2-ulopyranoses: a Simple Synthesis of New Aldehydo Tetrose Building Blocks

Legal Events

Date Code Title Description
ABAN Application deemed to be withdrawn (no publication fee paid)

Effective date: 20090205